Cargando…

Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study

Due to the large number of patients with severe coronavirus disease 2019 (COVID-19), many were treated outside the traditional walls of the intensive care unit (ICU), and in many cases, by personnel who were not trained in critical care. The clinical characteristics and the relative impact of caring...

Descripción completa

Detalles Bibliográficos
Autores principales: Reyes, Luis Felipe, Murthy, Srinivas, Garcia-Gallo, Esteban, Irvine, Mike, Merson, Laura, Martin-Loeches, Ignacio, Rello, Jordi, Taccone, Fabio S., Fowler, Robert A., Docherty, Annemarie B., Kartsonaki, Christiana, Aragao, Irene, Barrett, Peter W., Beane, Abigail, Burrell, Aidan, Cheng, Matthew Pellan, Christian, Michael D., Cidade, Jose Pedro, Citarella, Barbara Wanjiru, Donnelly, Christl A., Fernandes, Susana M., French, Craig, Haniffa, Rashan, Harrison, Ewen M., Ho, Antonia Ying Wai, Joseph, Mark, Khan, Irfan, Kho, Michelle E., Kildal, Anders Benjamin, Kutsogiannis, Demetrios, Lamontagne, François, Lee, Todd C., Bassi, Gianluigi Li, Lopez Revilla, Jose Wagner, Marquis, Catherine, Millar, Jonathan, Neto, Raul, Nichol, Alistair, Parke, Rachael, Pereira, Rui, Poli, Sergio, Povoa, Pedro, Ramanathan, Kollengode, Rewa, Oleksa, Riera, Jordi, Shrapnel, Sally, Silva, Maria Joao, Udy, Andrew, Uyeki, Timothy, Webb, Steve A., Wils, Evert-Jan, Rojek, Amanda, Olliaro, Piero L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669808/
https://www.ncbi.nlm.nih.gov/pubmed/35169585
http://dx.doi.org/10.1183/23120541.00552-2021
_version_ 1784614853425496064
author Reyes, Luis Felipe
Murthy, Srinivas
Garcia-Gallo, Esteban
Irvine, Mike
Merson, Laura
Martin-Loeches, Ignacio
Rello, Jordi
Taccone, Fabio S.
Fowler, Robert A.
Docherty, Annemarie B.
Kartsonaki, Christiana
Aragao, Irene
Barrett, Peter W.
Beane, Abigail
Burrell, Aidan
Cheng, Matthew Pellan
Christian, Michael D.
Cidade, Jose Pedro
Citarella, Barbara Wanjiru
Donnelly, Christl A.
Fernandes, Susana M.
French, Craig
Haniffa, Rashan
Harrison, Ewen M.
Ho, Antonia Ying Wai
Joseph, Mark
Khan, Irfan
Kho, Michelle E.
Kildal, Anders Benjamin
Kutsogiannis, Demetrios
Lamontagne, François
Lee, Todd C.
Bassi, Gianluigi Li
Lopez Revilla, Jose Wagner
Marquis, Catherine
Millar, Jonathan
Neto, Raul
Nichol, Alistair
Parke, Rachael
Pereira, Rui
Poli, Sergio
Povoa, Pedro
Ramanathan, Kollengode
Rewa, Oleksa
Riera, Jordi
Shrapnel, Sally
Silva, Maria Joao
Udy, Andrew
Uyeki, Timothy
Webb, Steve A.
Wils, Evert-Jan
Rojek, Amanda
Olliaro, Piero L.
author_facet Reyes, Luis Felipe
Murthy, Srinivas
Garcia-Gallo, Esteban
Irvine, Mike
Merson, Laura
Martin-Loeches, Ignacio
Rello, Jordi
Taccone, Fabio S.
Fowler, Robert A.
Docherty, Annemarie B.
Kartsonaki, Christiana
Aragao, Irene
Barrett, Peter W.
Beane, Abigail
Burrell, Aidan
Cheng, Matthew Pellan
Christian, Michael D.
Cidade, Jose Pedro
Citarella, Barbara Wanjiru
Donnelly, Christl A.
Fernandes, Susana M.
French, Craig
Haniffa, Rashan
Harrison, Ewen M.
Ho, Antonia Ying Wai
Joseph, Mark
Khan, Irfan
Kho, Michelle E.
Kildal, Anders Benjamin
Kutsogiannis, Demetrios
Lamontagne, François
Lee, Todd C.
Bassi, Gianluigi Li
Lopez Revilla, Jose Wagner
Marquis, Catherine
Millar, Jonathan
Neto, Raul
Nichol, Alistair
Parke, Rachael
Pereira, Rui
Poli, Sergio
Povoa, Pedro
Ramanathan, Kollengode
Rewa, Oleksa
Riera, Jordi
Shrapnel, Sally
Silva, Maria Joao
Udy, Andrew
Uyeki, Timothy
Webb, Steve A.
Wils, Evert-Jan
Rojek, Amanda
Olliaro, Piero L.
author_sort Reyes, Luis Felipe
collection PubMed
description Due to the large number of patients with severe coronavirus disease 2019 (COVID-19), many were treated outside the traditional walls of the intensive care unit (ICU), and in many cases, by personnel who were not trained in critical care. The clinical characteristics and the relative impact of caring for severe COVID-19 patients outside the ICU is unknown. This was a multinational, multicentre, prospective cohort study embedded in the International Severe Acute Respiratory and Emerging Infection Consortium World Health Organization COVID-19 platform. Severe COVID-19 patients were identified as those admitted to an ICU and/or those treated with one of the following treatments: invasive or noninvasive mechanical ventilation, high-flow nasal cannula, inotropes or vasopressors. A logistic generalised additive model was used to compare clinical outcomes among patients admitted or not to the ICU. A total of 40 440 patients from 43 countries and six continents were included in this analysis. Severe COVID-19 patients were frequently male (62.9%), older adults (median (interquartile range (IQR), 67 (55–78) years), and with at least one comorbidity (63.2%). The overall median (IQR) length of hospital stay was 10 (5–19) days and was longer in patients admitted to an ICU than in those who were cared for outside the ICU (12 (6–23) days versus 8 (4–15) days, p<0.0001). The 28-day fatality ratio was lower in ICU-admitted patients (30.7% (5797 out of 18 831) versus 39.0% (7532 out of 19 295), p<0.0001). Patients admitted to an ICU had a significantly lower probability of death than those who were not (adjusted OR 0.70, 95% CI 0.65–0.75; p<0.0001). Patients with severe COVID-19 admitted to an ICU had significantly lower 28-day fatality ratio than those cared for outside an ICU.
format Online
Article
Text
id pubmed-8669808
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-86698082021-12-15 Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study Reyes, Luis Felipe Murthy, Srinivas Garcia-Gallo, Esteban Irvine, Mike Merson, Laura Martin-Loeches, Ignacio Rello, Jordi Taccone, Fabio S. Fowler, Robert A. Docherty, Annemarie B. Kartsonaki, Christiana Aragao, Irene Barrett, Peter W. Beane, Abigail Burrell, Aidan Cheng, Matthew Pellan Christian, Michael D. Cidade, Jose Pedro Citarella, Barbara Wanjiru Donnelly, Christl A. Fernandes, Susana M. French, Craig Haniffa, Rashan Harrison, Ewen M. Ho, Antonia Ying Wai Joseph, Mark Khan, Irfan Kho, Michelle E. Kildal, Anders Benjamin Kutsogiannis, Demetrios Lamontagne, François Lee, Todd C. Bassi, Gianluigi Li Lopez Revilla, Jose Wagner Marquis, Catherine Millar, Jonathan Neto, Raul Nichol, Alistair Parke, Rachael Pereira, Rui Poli, Sergio Povoa, Pedro Ramanathan, Kollengode Rewa, Oleksa Riera, Jordi Shrapnel, Sally Silva, Maria Joao Udy, Andrew Uyeki, Timothy Webb, Steve A. Wils, Evert-Jan Rojek, Amanda Olliaro, Piero L. ERJ Open Res Original Research Articles Due to the large number of patients with severe coronavirus disease 2019 (COVID-19), many were treated outside the traditional walls of the intensive care unit (ICU), and in many cases, by personnel who were not trained in critical care. The clinical characteristics and the relative impact of caring for severe COVID-19 patients outside the ICU is unknown. This was a multinational, multicentre, prospective cohort study embedded in the International Severe Acute Respiratory and Emerging Infection Consortium World Health Organization COVID-19 platform. Severe COVID-19 patients were identified as those admitted to an ICU and/or those treated with one of the following treatments: invasive or noninvasive mechanical ventilation, high-flow nasal cannula, inotropes or vasopressors. A logistic generalised additive model was used to compare clinical outcomes among patients admitted or not to the ICU. A total of 40 440 patients from 43 countries and six continents were included in this analysis. Severe COVID-19 patients were frequently male (62.9%), older adults (median (interquartile range (IQR), 67 (55–78) years), and with at least one comorbidity (63.2%). The overall median (IQR) length of hospital stay was 10 (5–19) days and was longer in patients admitted to an ICU than in those who were cared for outside the ICU (12 (6–23) days versus 8 (4–15) days, p<0.0001). The 28-day fatality ratio was lower in ICU-admitted patients (30.7% (5797 out of 18 831) versus 39.0% (7532 out of 19 295), p<0.0001). Patients admitted to an ICU had a significantly lower probability of death than those who were not (adjusted OR 0.70, 95% CI 0.65–0.75; p<0.0001). Patients with severe COVID-19 admitted to an ICU had significantly lower 28-day fatality ratio than those cared for outside an ICU. European Respiratory Society 2022-02-14 /pmc/articles/PMC8669808/ /pubmed/35169585 http://dx.doi.org/10.1183/23120541.00552-2021 Text en Copyright ©The authors 2022 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org)
spellingShingle Original Research Articles
Reyes, Luis Felipe
Murthy, Srinivas
Garcia-Gallo, Esteban
Irvine, Mike
Merson, Laura
Martin-Loeches, Ignacio
Rello, Jordi
Taccone, Fabio S.
Fowler, Robert A.
Docherty, Annemarie B.
Kartsonaki, Christiana
Aragao, Irene
Barrett, Peter W.
Beane, Abigail
Burrell, Aidan
Cheng, Matthew Pellan
Christian, Michael D.
Cidade, Jose Pedro
Citarella, Barbara Wanjiru
Donnelly, Christl A.
Fernandes, Susana M.
French, Craig
Haniffa, Rashan
Harrison, Ewen M.
Ho, Antonia Ying Wai
Joseph, Mark
Khan, Irfan
Kho, Michelle E.
Kildal, Anders Benjamin
Kutsogiannis, Demetrios
Lamontagne, François
Lee, Todd C.
Bassi, Gianluigi Li
Lopez Revilla, Jose Wagner
Marquis, Catherine
Millar, Jonathan
Neto, Raul
Nichol, Alistair
Parke, Rachael
Pereira, Rui
Poli, Sergio
Povoa, Pedro
Ramanathan, Kollengode
Rewa, Oleksa
Riera, Jordi
Shrapnel, Sally
Silva, Maria Joao
Udy, Andrew
Uyeki, Timothy
Webb, Steve A.
Wils, Evert-Jan
Rojek, Amanda
Olliaro, Piero L.
Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study
title Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study
title_full Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study
title_fullStr Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study
title_full_unstemmed Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study
title_short Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study
title_sort clinical characteristics, risk factors and outcomes in patients with severe covid-19 registered in the international severe acute respiratory and emerging infection consortium who clinical characterisation protocol: a prospective, multinational, multicentre, observational study
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669808/
https://www.ncbi.nlm.nih.gov/pubmed/35169585
http://dx.doi.org/10.1183/23120541.00552-2021
work_keys_str_mv AT reyesluisfelipe clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT murthysrinivas clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT garciagalloesteban clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT irvinemike clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT mersonlaura clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT martinloechesignacio clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT rellojordi clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT tacconefabios clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT fowlerroberta clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT dochertyannemarieb clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT kartsonakichristiana clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT aragaoirene clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT barrettpeterw clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT beaneabigail clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT burrellaidan clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT chengmatthewpellan clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT christianmichaeld clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT cidadejosepedro clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT citarellabarbarawanjiru clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT donnellychristla clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT fernandessusanam clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT frenchcraig clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT haniffarashan clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT harrisonewenm clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT hoantoniayingwai clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT josephmark clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT khanirfan clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT khomichellee clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT kildalandersbenjamin clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT kutsogiannisdemetrios clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT lamontagnefrancois clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT leetoddc clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT bassigianluigili clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT lopezrevillajosewagner clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT marquiscatherine clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT millarjonathan clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT netoraul clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT nicholalistair clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT parkerachael clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT pereirarui clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT polisergio clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT povoapedro clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT ramanathankollengode clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT rewaoleksa clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT rierajordi clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT shrapnelsally clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT silvamariajoao clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT udyandrew clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT uyekitimothy clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT webbstevea clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT wilsevertjan clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT rojekamanda clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT olliaropierol clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy
AT clinicalcharacteristicsriskfactorsandoutcomesinpatientswithseverecovid19registeredintheinternationalsevereacuterespiratoryandemerginginfectionconsortiumwhoclinicalcharacterisationprotocolaprospectivemultinationalmulticentreobservationalstudy